InvestorsObserver
×
News Home

Is Phio Pharmaceuticals Corp (PHIO) Stock a Smart Value Wednesday?

Wednesday, January 25, 2023 01:46 PM | InvestorsObserver Analysts

Mentioned in this article

Is Phio Pharmaceuticals Corp (PHIO) Stock a Smart Value Wednesday?

Phio Pharmaceuticals Corp (PHIO) is around the top of the Healthcare sector according to InvestorsObserver. PHIO received an overall rating of 55, which means that it scores higher than 55% of stocks. Additionally, Phio Pharmaceuticals Corp scored a 71 in the Healthcare sector, ranking it higher than 71% of stocks in that sector.

Overall Score - 55
PHIO has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on PHIO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 55 would rank higher than 55 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Phio Pharmaceuticals Corp Stock Today?

Phio Pharmaceuticals Corp (PHIO) stock is trading at $0.51 as of 1:43 PM on Wednesday, Jan 25, a drop of -$0.03, or -5.56% from the previous closing price of $0.54. The stock has traded between $0.48 and $0.57 so far today. Volume today is less active than usual. So far 288,474 shares have traded compared to average volume of 503,340 shares. Click Here to get the full Stock Report for Phio Pharmaceuticals Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App